1887

Journal of Medical Microbiology logo

Volume 62, Issue 9

serovar Minnesota urosepsis in a patient with Crohn’s disease in the absence of recent or current gastrointestinal symptoms Free

Abstract

serovar Minnesota is a rarely isolated organism in clinical samples mainly grown from stool cultures. Sepsis due to is known in severely immunocompromised patients, but so far urosepsis due to serovar Minnesota has not been described. We report a case of a 31-year-old patient suffering from Crohn’s disease treated with infliximab and azathioprine, in whom was implanted a double-J ureteric catheter for urolithiasis. The patient presented with urinary tract infection and severe sepsis. serovar Minnesota was grown from urine and blood cultures. After empiric antimicrobial treatment with meropenem and vancomycin, treatment was changed to ceftriaxone. Antimicrobial treatment was continued for a total of 3 weeks without evidence of recurrence on follow-up visits. spp. rarely cause urinary tract infection and sepsis. However, in immunocompromised patients, non-typhoidal salmonellosis merits a thorough clinical and microbiological evaluation.

  • Received:
  • Accepted:
  • Published Online:
© 2013 SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.059352-0
2013-09-01
2024-04-30
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/9/1360.html?itemId=/content/journal/jmm/10.1099/jmm.0.059352-0&mimeType=html&fmt=ahah

References

  1. Borbolla L., Guerra Chabau A., Prieto E., Valledor T. 1956; [Meningitis caused by Salmonella minnesota; case report]. Rev Cubana Pediatr 28:611–618 (in Spanish) [PubMed]
     [Google Scholar]
  2. Cohen J. I., Bartlett J. A., Corey G. R. 1987; Extra-intestinal manifestations of salmonella infections. Medicine (Baltimore) 66:349–388[PubMed] [CrossRef]
     [Google Scholar]
  3. Dellinger R. P., Carlet J. M., Masur H., Gerlach H., Calandra T., Cohen J., Gea-Banacloche J., Keh D., Marshall J. C. other authors 2004; Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873 Erratum: Crit Care Med (2004) 32, 1448 (dosage error in article text); Crit Care Med (2004) 32, 2169–2170. [View Article][PubMed]
     [Google Scholar]
  4. Eckerle I., Zimmermann S., Kapaun A., Junghanss T. 2010; Salmonella enterica serovar Virchow bacteremia presenting as typhoid-like illness in an immunocompetent patient. J Clin Microbiol 48:2643–2644 [View Article][PubMed]
     [Google Scholar]
  5. EUCAST 2013; Clinical breakpoints. The European Committee on Antimicrobial Susceptibility Testing. http://www.eucast.org/clinical_breakpoints%5D
  6. Hinshaw W. R., McNeil E. 1945; Salmonella types isolated from snakes. Am J Vet Res 6:264–266[PubMed]
     [Google Scholar]
  7. Hoelzer K., Moreno Switt A. I., Wiedmann M. 2011; Animal contact as a source of human non-typhoidal salmonellosis. Vet Res 42:34 [View Article][PubMed]
     [Google Scholar]
  8. Hohmann E. L. 2001; Nontyphoidal salmonellosis. Clin Infect Dis 32:263–269 [View Article][PubMed]
     [Google Scholar]
  9. Lee L. A., Puhr N. D., Maloney E. K., Bean N. H., Tauxe R. V. 1994a; Increase in antimicrobial-resistant Salmonella infections in the United States, 1989–1990. J Infect Dis 170:128–134 [View Article][PubMed]
     [Google Scholar]
  10. Lee S. C., Yang P. H., Shieh W. B., Lasserre R. 1994b; Bacteremia due to non-typhi Salmonella: analysis of 64 cases and review. Clin Infect Dis 19:693–696 [View Article][PubMed]
     [Google Scholar]
  11. Mandal B. K., Brennand J. 1988; Bacteraemia in salmonellosis: a 15 year retrospective study from a regional infectious diseases unit. BMJ 297:1242–1243 [View Article][PubMed]
     [Google Scholar]
  12. McCracken D. A. 1954; Salmonella minnesota infection in Northamptonshire. J R Sanit Inst 74:1091–1094, discussion 1098–1100[PubMed]
     [Google Scholar]
  13. Ramos J. M., García-Corbeira P., Aguado J. M., Arjona R., Alés J. M., Soriano F. 1994; Clinical significance of primary vs. secondary bacteremia due to nontyphoid Salmonella in patients without AIDS. Clin Infect Dis 19:777–780 [View Article][PubMed]
     [Google Scholar]
  14. Ramos J. M., Aguado J. M., García-Corbeira P., Alés J. M., Soriano F. 1996; Clinical spectrum of urinary tract infections due on nontyphoidal Salmonella species. Clin Infect Dis 23:388–390 [View Article][PubMed]
     [Google Scholar]
  15. Saphra I., Winter J. W. 1957; Clinical manifestations of salmonellosis in man; an evaluation of 7779 human infections identified at the New York Salmonella Center. N Engl J Med 256:1128–1134 [View Article][PubMed]
     [Google Scholar]
  16. Stevenson J. E., Gay K., Barrett T. J., Medalla F., Chiller T. M., Angulo F. J. 2007; Increase in nalidixic acid resistance among non-Typhi Salmonella enterica isolates in the United States from 1996 to 2003. Antimicrob Agents Chemother 51:195–197 [View Article][PubMed]
     [Google Scholar]
  17. Weinberger M., Andorn N., Agmon V., Cohen D., Shohat T., Pitlik S. D. 2004; Blood invasiveness of Salmonella enterica as a function of age and serotype. Epidemiol Infect 132:1023–1028 [View Article][PubMed]
     [Google Scholar]
  18. Yen Y. F., Lin Y. C., Chen T. L., Chen Y. Y., Lin M. L., Wang F. D., Liu C. Y. 2007; Non-typhoidal Salmonella bacteremia in adults. J Microbiol Immunol Infect 40:227–233[PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.059352-0
Loading

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error